Moderna, Inc.

Healthcare · Biotechnology · United States

Last price 221.72 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 88.52B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provid...